Skip to main content
Log in

Tetanus toxin: Biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Single-chain tetanus toxin (toxin S) was prepared from short-term cultures by lysis under protection with protease inhibitors, precipitation with 40% ammonium sulfate, gel filtration, and chromatography on DEAE ion exchanger. Its limited proteolysis by trypsin, post-arginine cleaving enzyme from mouse submaxillary gland and clostripain led to bichainal derivatives (BT, BA, BCl) consisting of a heavy chain and a larger version of the light chain. The latter was then converted by trypsin into a small version which comigrated with the light chain of bichainal extracellular toxin (BE). The light chain produced by chymotrypsin (BC) and elastase (BEI) was of intermediate size. The nick region serves as substrate for all esteroproteases investigated and comprises between one and two kDa. Limited proteolysis increased the hydrophilicity (BT > BE > S) in hydrophobic interaction HPLC, and anionic behaviour (BC > BE > BT > S) in DEAE ion exchanger HPLC.

The bichainal toxins assessed (BC, BE or BT) were about two times more toxic than toxin S (LD50, mouse s. c. 2 ng/kg vs. 4 ng/kg). They were five to twelve times more potent than toxin S in three in vitro assays measuring the prevention of neurotransmitter release, i. c. on the phrenic nerve-hemidiaphragm preparation of the mouse (acetylcholine, with toxin BE and BT), on primary brain cell cultures from the mouse ([3H]noradrenaline, with toxin BE and BT), and on brain homogenate from rats ([3H]noradrenaline, with toxin BA, BC, BE and BT).

Thus single-chain toxin is a less potent precursor of, or protoxin for, various bichainal isotoxins. The term tetanus toxin covers a family of agents that differ by their posttranslational processing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

Toxin S:

single-chain tetanus toxin

toxin B:

bichainal tetanus toxins, prepared by treatment of toxin S with trypsin (BT), chymotrypsin (BC), post-arginine cleaving enzyme (BA), clostripain (BCI), or elatase (BEI)

toxin BE:

bichainal extracellular tetanus toxin

References

  • An der Lan B, Habig WH, Hardegree MC, Chrambach A (1980) Heterogeneity of 125I-labeled tetanus toxin in isoelectric focusing on polyacrylamide gel and polyacrylamide-gel electrophoresis. Arch Biochem Biophys 200:206–215

    Google Scholar 

  • Bergey GK, Habig WH, Lin C (1986) Nicking of tetanus toxin increases activity. Ann Neurol 20:137–138

    Google Scholar 

  • Bigalke H, Heller I, Bizzini B, Habermann E (1981) Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn-Schmiedeberg's Arch Pharmacol 316:244–251

    Google Scholar 

  • Chiu W, Rankert D, Cumming RA, Robinson JP (1982) Characterization of crystalline filtrate tetanus toxin. J Ultrastruct Res 79:285–293

    Google Scholar 

  • Critchley DR, Habig WH, Fishman PH (1986) Reevaluation of the role of gangliosides as receptors for tetanus toxin. J Neurochem 47:213–222

    Google Scholar 

  • DiMari SJ, Hash JH, Robinson JP (1982) Characterization of tetanus toxins and toxin components by amino terminal analysis. Arch Biochem Biophys 214:354–365

    Google Scholar 

  • Eisel U, Jarausch W, Goretzki K, Henschen A, Engels J, Weller U, Hudel M, Habermann E, Niemann H (1986) Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J 5:2495–2502

    Google Scholar 

  • Fairweather NF, Lyness VA (1986) The complete nucleotide sequence of tetanus toxin. Nuc Acid Res 14:7809–7812

    Google Scholar 

  • Habermann E (1988) Inhibition by tetanus and botulinum A toxin of the release of [3H]noradrenaline and [3H]GABA from rat brain homogenate. Experientia 44:224–226

    Google Scholar 

  • Habermann E, Albus U (1986) Interaction between tetanus toxin and rabbit kidney: A comparison with rat brain preparations. J Neurochem 46:1219–1226

    Google Scholar 

  • Habermann E, Dreyer F (1986) Clostridial neurotoxins: Handling and action at the cellular and molecular level. Current Topics Microbiol Immunol 129:93–179

    Google Scholar 

  • Habermann E, Tayot JL (1985) Interaction of solid-phase gangliosides with tetanus toxin and tetanus toxoid. Toxicon 23:913–920

    Google Scholar 

  • Habermann E, Dreyer F, Bigalke H (1980) Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn-Schmiedeberg's Arch Pharmacol 311:33–40

    Google Scholar 

  • Habermann E, Müller H, Hudel M (1988) Tetanus toxin, and botulinum A and C neurotoxins inhibit noradrenaline release from cultured mouse brain. J Neurochem 51 (in press)

  • Helting TB, Parschat S, Engelhardt H (1979) Structure of tetanus toxin. Demonstration and separation of a specific enzyme converting intracellular tetanus toxin to the extracellular form. J Biol Chem 254:10728–10733

    Google Scholar 

  • Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T 4. Nature 227: 680–685

    PubMed  Google Scholar 

  • Latham WC, Bent DF, Levine L (1962) Tetanus toxin production in the absence of protein. Appl Microbiol 10:146–152

    Google Scholar 

  • Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210

    Google Scholar 

  • Matsuda M, Yoneda M (1974) Dissociation of tetanus neurotoxin into two polypeptide fragments. Biochem Biophys Res Comm 57:1257–1262

    Google Scholar 

  • Montecucco C (1986) How does tetanus toxin bind to neuronal membranes? Trends Biochem Sci 11:314–317

    Google Scholar 

  • Mueller JH, Miller PA (1954) Variable factors influencing the production of tetanus toxin. J Bacteriol 68:271–277

    Google Scholar 

  • Neubauer V, Helting TB (1979) Structure of tetanus toxin. N-Terminal amino acid analysis of the two molecular forms of tetanus toxin and its composite chains. Biochem Biophys Res Commun 86:635–642

    Google Scholar 

  • Ozutsumi K, Sugimoto N, Matsuda M (1985) Rapid, simplified method for production and purification of tetanus toxin. Appl Environmental Microbio1 49:939–943

    Google Scholar 

  • Pierce EJ, Davison MD, Parton RG, Habig WH, Critchley DR (1986) Characterization of tetanus binding to rat brain membranes. Evidence for a high affinity proteinase-sensitive receptor. Biochem J 236:845–852

    Google Scholar 

  • Robinson JP, Hash JH (1982) A review of the molecular structure of tetanus toxin. Mol Cell Biochem 48:33–44

    Google Scholar 

  • Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155–188

    CAS  PubMed  Google Scholar 

  • van Heyningen S (1976) Binding of ganglioside by the chains of tetanus toxin. FEBS Lett 68:5–7

    Google Scholar 

  • Weller U, Taylor CF, Habermann E (1986) Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat. Toxicon 24:1055–1063

    Google Scholar 

  • Weller U, Mauler F, Habermann E (1988) Monochainal tetanus toxin: Preparation, protoxin properties and proteolytic conversion into isotoxins. Zbl Bacteriol Mikrobiol Hyg I. Abt Suppl 17:121–122

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to E. Habermann at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weller, U., Mauler, F. & Habermann, E. Tetanus toxin: Biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis. Naunyn-Schmiedeberg's Arch Pharmacol 338, 99–106 (1988). https://doi.org/10.1007/BF00174855

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00174855

Key words

Navigation